Serological Tests for COVID-19: Potential Opportunities

Link to article at PubMed

Cell Biol Int. 2020 Dec 2. doi: 10.1002/cbin.11516. Online ahead of print.


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific IgM and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge. This article is protected by copyright. All rights reserved.

PMID:33289157 | DOI:10.1002/cbin.11516

Leave a Reply

Your email address will not be published. Required fields are marked *